Cytological and Immunocytochemical Study of Bronchial Wash in Bronchogenic Carcinoma
DOI:
https://doi.org/10.32007/jfacmedbagdad.4841471Keywords:
Cytological and ImmunocytochemicalAbstract
Background: - Carcinoma of the lung has became the most common type of cancer since 1985 & the most common cause of cancer death in both males & females.
Aim of study: - To assess the diagnostic accuracy of bronchial wash cytology & application of immunocytochemical methods, using two tumor markers (low molecular weight cytokeratin & epithelial membrane antigen) for more accurate & precise diagnosis of lung tumors.
Patients, materials and methods: - Fifty fifes suspected lung cancer cases according to their clinicoradiological examinations were included in this study.
Bronchial wash cytology was performed for all the 55 patients. Smears were stained by conventional cytological stain in addition to immunocytochemial staining using low molecular weight cytokeratin & epithelial membrane antigen. The final results of bronchial wash were compared to histopathological results & final clinical diagnosis as.
Results: - Cytological smears of bronchial wash revealed the presence of malignant cells in 33 cases (60%). The sensitivity of bronchial wash cytology was 82.5%; the specificity was 100.0%, with overall accuracy of 87.3%. Using cytokeratin staining, 26 cases (47%) were positive for malignant cells, & 29 were negative. The sensitivity, specificity & overall accuracy were 65%, 100%, & 74.5% respectively. With EMA staining, 19 cases (27%) were positive for malignant cells & 36 were negative. The sensitivity, specificity & overall accuracy were 47.5%, 100%, & 61.8% respectively. Combined use of CK & EMA raised the sensitivity to 72.5%, specificity of 100% & overall accuracy of 80%. Combined use of monoclonal antibodies & conventional cytology raised the sensitivity to 95%, specificity 100%, with overall accuracy of 96.3%.
Conclusions: - Using more than one monoclonal antibody, or using combined conventional cytology & immunocytochemistry increase the sensitivity for detection of malignant cells in bronchial wash smears.
Downloads
References
Robbins SL, Cotran RS, Kumer V, Collin. Pathological basis of disease, vol 2, six editions, 1999
2-Iraqi cancer registry center. Results of Iraqi cancer registry 1998, 1999, 2000.
3-Einstein VL, Mustaechi D, Osanm KE. Epidemiology of Lung cancer. In: Murry, Nadel (eds). Textbook of Respiratory Medicine, 2nd ed., vol. II, W.B Saunders Company, Philadelphia, 1994; 1504-52.
4-Rosi J, Ackerman Surgical Pathology. Vol 1, eight editions, Mospy co 1996:338-435
5- Murry L, Lan W, ESTTEET, oxford handbook of clinical Medicine, fifth ed., Longmore Wilkinson 2001.
6- AL-Rawi FA. Bronchial wash in the diagnosis of lung lesions. Iraqi J Med. Sci. 2004; 3: 125-127
7- Vank-Noordegraaf A, Postmus PA, Stuedja TG. Bronchoscopic treatment of patients with intraluminal micro invasive radio graphically occult lung cancer not eligible for surgical resection: a fallow up study. Lung cancer 2003; 39:49-53.
8- MarLuce bibbo, Comprehensive cytopathology, Second edition, Vol 1, W.B Sanders Company, 1997
9- Sabiston. Text book of surgery. 16th edition. The biological basis of modern surgical practice. W.R. Saunderse company.
10-Kato H, Konaka C, Masayoshi TH , Hyata YH Cytology of the lung technique and interpretation , 1St edition , IGAKU-Shoin
Ltd, Tokyo ,1983.
11- Resenthal DL. Monographs in clinical oncology: cytopathology of pulmonary diseases,Weild GL Ohio, 1988.
12- Said JW, Vimads LS, Nash G, Shintaka P, Heusser RC, Sassoon AF, Loyd RV. Immunoreactive; neuron specific enolases, Bobsein. and chromogranin as markers for neuroendocrine lung tumor. Cancer 1985; 16:236-240.
13- Vincent RG, Pickren JW, Lane WW, Bross I, Takita H, Houten Let al. The changing histopathology of Lung cancer a review of 1682 cases. Cancer 1977, 39:1646-1655.
14- Santose Martines MJ, Curull V, Blanco ML, Macia F, Mojal S, Vila J, Braquestas of Lung cancer at University Hospital, Epidemiological and histological characteristics of a recent and a historical series. Arch Bronchoneumol 2005; 41:307-312
15- Jassim MA. Bronchogenic carcinoma: Bronchial Brushing, Washing and post Bronchoscope sputum, cytological
examination, Sept. 1998.
16 Mazin A. Changing Pattern of Lung Cancer: A pathological and immunohistochemical study. March 2001
17- Donald WK, Raphael EP, Ralph R, Weishselbaum RC, Bast JK, Tadsghadand JS, Frei E. Cancer medicine 5"' edition. ACS and BDC Decker Inc 2000.
18- Ahmed A, Ahmed S. Comparison of Bronchoalveolar Lavage cytology in the diagnosis of carcinoma of the Lung. J Ayub Med. Cell Abbottabad 2004; 16:29-33.
19- Rodeny TM, Technical immunohistochemistry. achieving reliability and Reproducibility of immunostains, Society for applied immunohistochemistry 2001 annual meeting.
20-- Tsubokawa F, Nishisaka TR, Takeshima Y. Heterogeneity of expression of cytokeratin subtypes ins squamous cell carcinoma of the lung with special reference to CK14 over expression in cancer of high-proliferative and Lymphogeneous metastatic potential. Pathology International 2002; 52:286-293.
21- Chu PG, Lyda MH, Weiss LM. cytokeratin 14 expression in epithelial neoplasm: a survey of 435 cases with emphasis or its value in differentiating squamous cell carcinoma from other epithelial tumor. 1-listopathology 2001, 29:9-11
22- Kyrkou KA, latridis SG, Athanassiadou PP, Lambropoulou S. Immunodetection of neuron specific enoalse and keratin in cytological preparation as an aid in the differential diagnosis of Lung cancer. Diagnostic Cytopathology 1986; 2,217-220.
23-- Said JW Nash G, Teppa G, Banks, Schlegels. Keratin protein and carcinoembryonic Antigen in lung carcinoma. Human Pathology 1983; 14:70-6.
24-- Nagle RB, Mc Danial KM, Clank VA, Payne CM. The use of antikeratin antibodies in the diagnosis of human neoplasms. Am J Clin Pathol 1983;79:458-66.
25- Domagala-Kulawik J, Guzman J, Costabel V. immune cells in bronchoalveolar Lavage in peripheral Lung cancer analysis of 140 cases. Respiration 2003; 70:43-8
26-- Weinberg ES, Daneil D, Laura W, Nazeel A, Jayesh P, Ardeshir H et al. cytokeratin staining for interoperative evaluation of sentinel Lymph node in patients with invasive lobular carcinoma. Am J of Surgery 188:419-422.
27- Rosell A, Monso E, Lores L, Villax Liatjos M, Ruiz J, Morera J. cytology of bronchial biopsy rinse fluid to improve the diagnostic yield for Lungs cancer. Eur Respire J 1998; 12:1415-1418.
Creative Commons Attribution 4.0 International license..
